Monoclonal Antibody for COVID Gets FDA Emergency Use Authorization
The FDA on Tuesday granted emergency use authorization to Inflarx NV's monoclonal antibody for the treatment of hospitalized COVID patients.
Reuters Health Information
source https://www.medscape.com/viewarticle/990441?src=rss
Reuters Health Information
source https://www.medscape.com/viewarticle/990441?src=rss
Comments
Post a Comment